HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 17.25
+0.10 (0.58%)
Sep 10, 2025, 12:00 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 14.39 billion as of September 9, 2025. Its market cap has increased by 1,450.46% in one year.
Market Cap
14.39B
Enterprise Value
12.39B
Revenue
908.35M
Ranking
n/a
PE Ratio
23.72
Stock Price
17.25
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 14.39B, an increase of 70.05%. That is a compound annual growth rate of 11.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 14.39B | 956.20% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | 8.11B | -4.17% |
| Dec 10, 2020 | 8.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.19B |
| Hansoh Pharmaceutical Group Company | 231.38B |
| JD Health International | 204.41B |
| Innovent Biologics | 176.58B |
| Sino Biopharmaceutical | 161.14B |
| WuXi Biologics | 150.75B |
| Akeso | 142.50B |
| CSPC Pharmaceutical Group | 127.94B |